Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.
Saved in:
| Title: | Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3. |
|---|---|
| Authors: | Younossi, Z. M.1 zobair.younossi@inova.org, Stepanova, M.2, Jacobson, I. M.3, Asselah, T.4, Gane, E. J.5, Lawitz, E.6, Foster, G. R.7, Roberts, S. K.8, Thompson, A. J.8, Willems, B. E.9, Welzel, T. M.10, Pearlman, B.11, Younossi, I.2, Racila, A.1, Henry, L.2 |
| Source: | Alimentary Pharmacology & Therapeutics. Jan2018, Vol. 47 Issue 2, p259-267. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 02692813 |
|---|---|
| DOI: | 10.1111/apt.14423 |
